Press Release Services and Business News from Send2Press, a unit of Neotrope, established 1983
Press Release Writing and Distribution
  Thursday, December 08, 2016 Neotrope®
Public Relations
Press Release Services and Media Relations
Send2Press® - Press Release Writing, Newswire Distribution, Press Release Optimization, Internet Marketing, Podcasting, SEO, Media Monitoring, Media Coaching, News Syndication, Book Marketing, Entertainment News, Web PR, and Media Relations since 1983   media relations
press release writing
Press Release Services and Business News from Send2Press, a unit of Neotrope, established 1983
 
NEWS WIRES:
» Ad Industry News
» Aerospace News
» Arts News
» Automobile News
» Biotech News
» Book News
» Business News
» Computer Industry News
» Construction News
» DotCom News
» eCommerce News
» Education News
» eMarketing News
» Entertainment News
» Employment News
» Energy News
» Family/Parenting News
» Fashion Industry News
» Fitness Industry News
» Food & Cooking News
» Graphics News
» Insurance News
» Interior Design News
» Internet News
» Investor News
» Manufacturing News
» Medical News
» Music News
» NonProfit News
» Peace/Ecology News
» Podcasting News
» Political News
» Real Estate News
» Religion News
» Retail News
» Security Solutions News
» Small Cap & OTC News
» Software Industry News
» Sports News
» Telecom News
» Travel Industry News
» TV & Cable News
» VoIP News
» US Newswires
» Business Profiles
» More News Channels
» Today's Headlines

Distribute your News with Send2Press® Press Release Services

 

Medical Technology News
Recent Newswire Stories from PRnetwire™ and eNewsChannels.com™

Edited by Christopher Simmons, senior news editor


Health Discovery Corporation, Inc. Announces the Appointment of Joe Fanelli to the Management Team as Director of Corporate Development

WACO, Texas - Nov. 14, 2003 /Send2Press Newswire/ -- Health Discovery Corporation, Inc. (OTC BB: HDVY), today announced the appointment of Joe Fanelli to the Company's Management Team. Mr. Fanelli will assume the position of Director of Corporate Development for the Company. In this role, Mr. Fanelli will work on strategic alliances, partnerships, acquisitions, and licensees for the Company's patent protected biomarker discoveries.

Mr. Fanelli brings to the Company extensive experience in strategic planning, as well as business and product development in the biotechnology arena. Specifically, Mr. Fanelli has been in executive management positions for more than 20 years, including Beckman Instruments, which was acquired by SmithKline. He then joined Cetus Corporation as Director and General Manager of their Instrument Division, which was acquired 3 years later, along with the PCR amplification technology, by Perkin Elmer.

Thereafter, Mr. Fanelli served at the Vice President level of Marketing, Sales and Business Development at emerging growth companies in the Biotechnology Market Sector including American Bionetics, Cangene Corporation, Microgenics Corporation, Quantum Biotechnologies and Structural Bioinformatics. He participated in the acquisition of two companies and played a key role in starting and growing multi-million dollar biomedical research companies; three of which had successful initial public stock offerings (IPO's). Mr. Fanelli earned a Master's Degree in Biological Sciences from California State University, Fullerton.

Stephen D. Barnhill, M.D., Chairman and Chief Executive Officer of Health Discovery Corporation stated, "We are pleased to have Joe Fanelli join our management team as Director of Corporate Development." Dr. Barnhill continued, "We look forward to expanding our corporate objectives in biomarker discovery with the expertise and experience provided by Mr. Fanelli as we continue to position ourselves in the international diagnostic and drug discovery market."

Mr. Fanelli said, "I am looking forward to working with Dr. Barnhill and the very impressive team being assembled within Health Discovery Corporation." Mr. Fanelli continued, "The dawn of the post-genome era is leading to extraordinary opportunities in biomedicine with post-genomic biomarker-based diagnostic products being projected to grow from $100 million in 2003 to $2 billion by 2008. It will be exciting to be an integral part of the management team of Health Discovery Corporation as the Company positions itself in biomarker discovery."

This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.


Organization Website: www.dwcell.com
Source of News: Health Discovery Corporation

Find More Stock Info, Charts, News on OTC BB: HDVY
Yahoo!® Finance (HDVY.OB)
Quote.com (BB:HDVY)
MSN Money (HDVY)

Texas Technology Newswire / Medical Technology Newswire

» Read original news release in text format
» Read original news release in PDF format
» E-mail This News Story to Someone
» Sign-up for Free News Alerts by E-mail



• Previous News from Health Discovery Corporation


Find more news like this:
> More Medical Technology News
> More Texas Business and Technology News
> Other Recent News Stories
> Other Newswire Channels



FOR INFORMATION ABOUT THE COMPANY OR ORGANIZATION(S) MENTIONED IN THE ABOVE NEWS ITEM, PLEASE CONTACT THE COMPANY DIRECTLY. SEND2PRESS/NEOTROPE IS NOT A REPRESENTATIVE OF, AND DOES NOT OFFER FURTHER INFORMATION ABOUT, ANY COMPANY MENTIONED IN THE ABOVE NEWS ITEM(S).

DISCLAIMER: the above news article is believed accurate but not guaranteed, and is based on news supplied by the company or organization mentioned and/or quoted in the story. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. Reproduction of this news article in any form requires written authorization. You may freely link to this article. PRnetwire™ (www.PRnetwire.com) is a unit of Neotrope, and is not related to PR Newswire®. Keyword marketing technology by DotComMojo™, a unit of Neotrope.  
NEWSWIRE TERMS OF USE



Add Our News Headlines to Your Website Free
Free headline feed


Journalists & Editors
Choose your news by preferred topic(s).
Privacy protected.
MORE INFO

Archived Releases

Most Recent Releases


Subscribe to RSS Feed



NOTICE: THIS PAGE IS ARCHIVAL CONTENT AND SHOULD NOT BE RELIED UPON FOR ACCURACY.
Top of Page | Home Page | E-mail This News Story
— PLEASE SUPPORT OUR NEWSWIRE ARCHIVE SPONSORS —
Press Release Services from Send2Press
Click Links Below to Learn More About Business Promotion Services:
Press Release Services from Send2Press   |   Press Release Writing Services
Search Engine Marketing Services for Your Website   |   Website Design
Mindset Interactive, Mindset Design, Mindset Communications, Mindset Advertising, Mindset Netwire
 Copr. © 1983-2014 Neotrope® — all rights reserved. Privacy/Legal Statements 
Press Release Services and Business News from Send2Press, a unit of Neotrope, established 1983
Press Release Writing
Business Press Release Services | Compare News Distribution Plans | Agency Program | How to Order
PR Services Add-on Options | Price List | SEO+PR™ Services | Press Release Writing | Publication Lists
Client Testimonials | About Us | Contact Us | Newswire Channels |
News About Send2Press | | RSS/XML Feed

Free News Articles